Asia Pacific Typhoid Fever Vaccines Market to Grow at a CAGR of 10.0% to reach US$ 135.79 million from 2020 to 2027

Asia Pacific Typhoid Fever Vaccines Market Forecast to 2027 - Covid-17 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable) and Country

Publication Month: Nov 2020 | Report Code: TIPRE00016285 | No. of Pages: 90 | Category: Pharmaceuticals | Status: Published
Covid

The Asia Pacific typhoid fever vaccines  market is expected to reach US$ 135.79 million in 2027 from US$ 64.75  million in 2019. The market is estimated to grow with a CAGR of 10.0%from 2020-2027.

Key factors that are driving growth of the market are rising prevalence of typhoid, and increase in support for typhoid immunization. However, side-effects associated with typhoid fever vaccines hinder the market growth.

 

Typhoid fever is the most common bacterial infection among the Asian countries. Enteric fever is transmitted through contaminated food and water with human waste. Due to poor sanitation facilities in Asian countries, the prevalence of typhoid in Asian countries is high.

According to the recent estimates of the World Health Organization (WHO), typhoid is an endemic fever in Africa, Asia, Latin America, Oceania, and the Caribbean. The WHO also states that 80% of the typhoid fever cases arise from India, Bangladesh, China, Laos, Nepal, Indonesia, Vietnam, and Pakistan.

Furthermore, as per the study ‘Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities’ published in 2019, about seven million people are infected with typhoid each year in South Asia with around 75 000 deaths.  As per the recent study by the All India Institute of Medical Sciences (AIIMS), around 494 per 100,000 children of age group 5–15 years suffered from typhoid in 2017.

Thus, the growing incidence of enteric fever (typhoid) in Asian countries is likely to drive the demand for typhoid vaccines in Asian countries during the forecast period.

 

Furthermore, Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19. As per the data of Worldometer, as of counts as of October 06, 2020, China reported 85,482 COVID-19 cases, while in Japan, it stood at 85,739, India recorded 6,685,082 cases, and Australia reported 27,173 confirmed cases. In India, which reported a new daily high of 70,000 cases, nearly a dozen states have imposed a partial lockdown in high-risk areas. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission.

.

Rest of Asia Pacific Typhoid Fever Vaccines  Market Revenue and Forecast to 2027 (US$ Mn)

Rest of Asia Pacific Typhoid Fever Vaccines  Market Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :


 

 

Asia Pacific Typhoid Fever Vaccines  – Market Segmentation

 

By Vaccine Type

  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others

By Route of Administration

  • Oral
  • Injectable

By Country

  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Rest of Asia Pacific

Company Profiles

  • GlaxoSmithKline plc
  • Shanghai institute of biological products co. Ltd.
  • PT Bio Farma
  • BIO-MED
  • BHARAT BIOTECH

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia Pacific  Typhoid Fever Vaccines Market – By Vaccine Type

1.3.2        Asia Pacific  Typhoid Fever Vaccines Market – By Route of Administration

1.3.3        Asia Pacific  Typhoid Fever Vaccines Market – By Country

2.          Asia Pacific  Typhoid Fever Vaccines Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Asia Pacific  Typhoid Fever Vaccines Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Asia Pacific  Typhoid Fever Vaccines Market - Asia Pacific  PEST Analysis

4.3        Expert Opinion

5.          Asia Pacific  Typhoid Fever Vaccines Market  Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Increasing Prevalence of Typhoid Fever in Asia

5.1.2        Typhoid Immunizations Programs

5.2        Key Restraints

5.2.1        Risks Associated with Typhoid Fever Vaccines

5.3        Key Market Opportunities

5.3.1        Growing Pharmaceutical and Biopharmaceutical Industry in Asia

5.4        Future Trend

5.4.1        Product Development and Launches in the Asia Pacific Region

5.5        Impact Analysis

6.          Typhoid Fever Vaccines Market – Asia Pacific  Analysis

6.1        Asia Pacific  Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7.          Typhoid Fever Vaccines Market – By Vaccine Type

7.1        Overview

7.2        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

7.3        Live Attenuated Vaccine

7.3.1        Overview

7.3.2        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Capsular Polysaccharide Vaccines

7.5.1        Overview

7.5.2        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Conjugate Vaccine

7.6.1        Overview

7.6.2        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7        Others

7.7.1        Overview

7.7.2        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.          Typhoid Fever Vaccines Market Analysis – By Route of Administration

8.1        Overview

8.2        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

8.2.1        Oral

8.2.1.1          Overview

8.2.2        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.3        Injectable

8.3.1        Overview

8.3.2        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.          Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1        Asia Pacific: Typhoid Fever Vaccines Market

9.1.1        Overview

9.1.2        Asia Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.1.3        Asia Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.4        Asia Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.5        Asia Pacific: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)

9.1.6        China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          China: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.6.3          China: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.7        Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Japan: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.7.3          Japan: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.8        India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          India: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.8.3          India: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.9        South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1          South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2          South Korea: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.9.3          South Korea: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.10     Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1       Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2       Australia: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.10.3       Australia: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.11     Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.1       Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.2       Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.11.3       Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

10.       Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

10.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.       Company Profiles

11.1      Shanghai Institute of Biological Products Co., Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      PT Bio Farma

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      BIO-MED

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Bharat Biotech

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      GlaxoSmithKline plc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

 

LIST OF TABLES

Table 1.            Asia Pacific Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 2.            Asia Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 3.            China Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 4.            China Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 5.            Japan Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            Japan Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 7.            India Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 8.            India Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 9.            South Korea Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          South Korea Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.          Australia Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Australia Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 13.          Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 1.            Glossary of Terms, Asia Pacific  Typhoid Fever Vaccines Market

 

LIST OF FIGURES

Figure 1.           Typhoid Fever Vaccines Market Segmentation

Figure 2.           Asia Pacific  Typhoid Fever Vaccines Market Overview

Figure 3.           Capsular Polysaccharide Vaccines Segment Held Largest Share of Typhoid Fever Vaccines Market

Figure 4.           Asia Pacific  Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)

Figure 5.           Asia Pacific  : PEST Analysis

Figure 6.           Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints

Figure 7.           Asia Pacific  Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

Figure 9.           Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 14.        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Asia Pacific: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 17.        Asia Pacific Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 18.        China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 19.        Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 20.        India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Asia Pacific Countries

 

  1. GlaxoSmithKline plc
  2. Shanghai institute of biological products co., Ltd
  3. PT Bio Farma
  4. BIO-MED
  5. BHARAT BIOTECH
  • To understand the Asia Pacific typhoid fever vaccines  market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific typhoid fever vaccines  market
  • Efficiently plan M&A and partnership deals in Asia Pacific typhoid fever vaccines  market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific typhoid fever vaccines  market
  • Obtain market revenue forecast for market by various segments from 2019-2027 in Asia Pacific.
TIPRE00016285
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing